Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$383M |
| 2 |
Costco
COST
|
+$267M |
| 3 |
Pfizer
PFE
|
+$231M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$227M |
Top Sells
| 1 |
CVS Health
CVS
|
+$258M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL RESOURCES INC (HOLDING CO)
GAS
|
+$216M |
| 4 |
Charter Communications
CHTR
|
+$142M |
| 5 |
TE
TECO ENERGY INC
TE
|
+$136M |
Sector Composition
| 1 | Technology | 15.67% |
| 2 | Healthcare | 12.42% |
| 3 | Financials | 11.99% |
| 4 | Consumer Staples | 9.63% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
726
McCormick & Company Non-Voting
MKC
$18.4B
| $19.3M | 0.03% |
385,600
+44,600
| +13% | +$2.23M |
|
727
Insulet
PODD
$23.8B
| $19.3M | 0.03% |
470,400
-150,492
| -24% | -$6.16M |
|
|
MTSC
728
DELISTED
MTS Systems Corp
MTSC
| $19.2M | 0.03% |
417,318
-13,500
| -3% | -$621K |
|
729
Shutterstock
SSTK
$715M
| $19.2M | 0.03% |
300,900
+82,000
| +37% | +$5.22M |
|
730
Pinnacle West Capital
PNW
$10.5B
| $19.1M | 0.03% |
251,900
-167,000
| -40% | -$12.7M |
|
731
TransUnion
TRU
$17.5B
| $19.1M | 0.03% |
554,100
+62,600
| +13% | +$2.16M |
|
732
Culp
CULP
$59.2M
| $19.1M | 0.03% |
640,729
-2,371
| -0.4% | -$70.6K |
|
|
FSP
733
Franklin Street Properties
FSP
$172M
| $19.1M | 0.03% |
1,513,900
+124,000
| +9% | +$1.56M |
|
|
BEAT
734
DELISTED
BioTelemetry, Inc.
BEAT
| $19.1M | 0.03% |
1,027,200
+103,568
| +11% | +$1.92M |
|
|
ANAT
735
DELISTED
American National Group, Inc. Common Stock
ANAT
| $19M | 0.03% |
156,000
+6,300
| +4% | +$768K |
|
|
XXIA
736
DELISTED
Ixia
XXIA
| $19M | 0.03% |
1,520,220
-162,285
| -10% | -$2.03M |
|
|
UHT
737
Universal Health Realty Income Trust
UHT
$569M
| $19M | 0.03% |
300,800
+38,000
| +14% | +$2.39M |
|
|
PE
738
DELISTED
PARSLEY ENERGY INC
PE
| $19M | 0.03% |
565,600
-199,100
| -26% | -$6.67M |
|
739
H&R Block
HRB
$6.73B
| $18.9M | 0.03% |
816,400
-33,900
| -4% | -$785K |
|
740
Healthcare Realty
HR
$6.44B
| $18.9M | 0.03% |
579,100
+337,828
| +140% | +$11M |
|
|
TCO
741
DELISTED
Taubman Centers Inc.
TCO
| $18.9M | 0.03% |
253,800
-92,100
| -27% | -$6.85M |
|
|
HMSY
742
DELISTED
HMS Holdings Corp.
HMSY
| $18.9M | 0.03% |
851,600
-60,112
| -7% | -$1.33M |
|
743
AMC Entertainment Holdings
AMC
$1.42B
| $18.8M | 0.03% |
60,620
+22,120
| +57% | +$6.88M |
|
744
United Rentals
URI
$60.8B
| $18.8M | 0.03% |
+240,023
| New | +$18.8M |
|
|
PHH
745
DELISTED
PHH Corporation
PHH
| $18.8M | 0.03% |
1,297,900
+366,500
| +39% | +$5.3M |
|
746
Stepan Co
SCL
$1.09B
| $18.7M | 0.03% |
257,300
+21,800
| +9% | +$1.58M |
|
|
GTY
747
Getty Realty Corp
GTY
$1.6B
| $18.7M | 0.03% |
780,386
-26,500
| -3% | -$634K |
|
|
CPE
748
DELISTED
Callon Petroleum Company
CPE
| $18.7M | 0.03% |
118,919
+59,290
| +99% | +$9.31M |
|
749
TechnipFMC
FTI
$16.8B
| $18.7M | 0.03% |
845,645
-1,353,542
| -62% | -$29.9M |
|
750
Enanta Pharmaceuticals
ENTA
$178M
| $18.7M | 0.03% |
701,400
+549,200
| +361% | +$14.6M |
|